In addition, a comparative clinical cohort of prostate cancer tissue was analysed for expression of IGF-II and H19 mRNA using digital droplet polymerase chain reaction (ddPCR) and compared with two larger publicly available patient cohorts from the Cancer Genome Atlas (TGCA). The gene discussed is IGF2; the disease is prostate carcinoma.